Liranaftate API is a synthetic antifungal active pharmaceutical ingredient belonging to the thiocarbamate class of antifungal compounds. It has been investigated primarily for topical treatment of superficial fungal infections, particularly infections affecting the skin and nails. Liranaftate acts by interfering with fungal sterol biosynthesis, an important pathway required for maintaining the integrity and function of fungal cell membranes.
Liranaftate is chemically identified as a thiocarbamate derivative and has been investigated as a topical antifungal agent because of its activity against dermatophytes and other pathogenic fungi. The compound has attracted pharmaceutical-development interest in the areas of dermatology, topical antifungal formulations, onychomycosis research and superficial fungal infection treatment.
The compound is particularly associated with research into tinea infections and onychomycosis, where topical delivery can provide localized exposure at the site of fungal infection. Its mechanism is associated with inhibition of fungal sterol-related biochemical pathways, ultimately impairing fungal growth and viability.
MEDIOCON INC supplies Liranaftate for applicable pharmaceutical research, topical formulation development, analytical applications and bulk API requirements, subject to product availability, applicable specifications, regulatory requirements and supporting documentation. The exact grade, assay, impurity profile, particle characteristics, packaging, storage conditions and Certificate of Analysis should be confirmed for the specific batch before use.
Because Liranaftate is a specialized antifungal compound rather than a widely standardized general pharmaceutical API, product-specific analytical specifications should be taken from the applicable validated method and actual manufacturer COA rather than transferring limits from another antifungal API.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Liranaftate API Manufacturer & Supplier in India | MEDIOCON INC (CAS 111279-33-9) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Liranaftate API Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance